Horizontal Transmission of Recombinant Vaccinia Virus in Strain 13 Guinea Pigs

Contemporary Topics in Laboratory Animal Science

Volumn 41, Issue 2, 2002, Pages 57-60

  Holt, Rebecca K ^a   Walker, Brian K ^a   Ruff, Albert J ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ANIMAL HOUSING; ARTICLE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; IMMUNOLOGY; MALE; PATHOGENICITY; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINIA; VACCINIA VIRUS;

ANIMALS; ANTIBODIES, VIRAL; DISEASE TRANSMISSION, HORIZONTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIGS; HOUSING, ANIMAL; INJECTIONS, SUBCUTANEOUS; MALE; VACCINES, SYNTHETIC; VACCINIA; VACCINIA VIRUS;

EID: 0036512192     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Maramorosch, K., F. A. Murphy, and A. J. Shatkin. 1988. Vaccinia: virus, vector, vaccine, p. 43-64. In K. Maramorosch (ed.), Advances in virus research, vol. 34. Academic Press, Inc., New York.
2. Goldsby, R. A., T.J. Kindt and B. A. Osborne. 2000. The immune system in health and disease, p. 458-462. In R. A. Goldsby (ed.), Kuby immunology, 4th ed. W. H. Freeman and Co., New York.
3. Mandell, G. L., J. E. Bennett, and R. Dolin. 2000. Vaccinia virus (cowpox), p. 1553-1555. In G. L. Mandell (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingston, Philadelphia.
4. Mims, D. A., A. Nash, and J. Stephen. 2001. Vaccines and how they work, p. 400-415. In D. A. Mims, Mims' pathogenesis of infectious disease, 5th ed. Academic Press, New York.
5. Lederberg, J. 1999. Biological warfare: a historical perspective, p. 18. In J. Lederberg, Biological weapons: limiting the threat. The MIT Press, Cambridge, Mass.
6. Strickland, G. T. 2000. Poxviruses, p. 207-210. In G. T. Strickland (ed.), Hunter's tropical medicine and emerging infectious diseases. W. B. Saunders Co., Philadelphia.
7. Mandell, G. L., J. E. Bennett, and R. Dolin. 2000. Introduction to poxviridae, p. 1552. In G. L. Mandell (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingston, Philadelphia.
8. Wittek, R. 1994. Vaccinia virus, p. 1507-1512. In R.G. Webster and A. Granoff (ed.), Encyclopedia of virology, vol. 3. Academic Press, Inc., New York.
9. Moss, B. 1991. Vaccinia virus: a tool for research and development. Science 252:1662-1667.
10. Paoletti, E. 1996. Application of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA 93:11349-11353.
11. Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health. 1998. Accelerated development of vaccines. Jordan Rep.98:68-69.
12. Gilligan, K. J., J. B. Geisbert, P. B. Jahrling, and K. A. Anderson. 1997. Assessment of protective immunity conferred by recombinant vaccinia viruses to guinea pigs challenged with Ebola virus, p. 87-92. In Vaccines 97. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
13. Wittek, R. 1994. Vaccinia virus, p. 1507-1528. In R. G. Webster (ed.), Encyclopedia of virology, vol. 3. Academic Press, New York.
14. Centers for Disease Control. 2001. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. Morbid. Mortal. World Rep. 50(RR-10):1-10.
15. National Institutes of Health. 1998. Guidelines for research involving recombinant DNA molecules. Fed. Regist. 59:FR34496.
16. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academic Press, Washington, D.C.
17. McClain, D. J., S. Harrison, C. L. Yeager, et al. 1997. Immunologic responses to vaccinia vaccines administered by different parenteral routes. J. Infect. Dis. 175:756-763.
18. Iacono-Connors, L.C., C. S. Schmaljohn, and J. M. Dalrymple. 1990. Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants. Infect. Immun. 58:366-372.
19. Yong, K. C., C. Rossi, J. W. Leduc, et al. 1994. Serologic relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology 198:196-204.
20. Meegan, J.M., B.A. Yedloutschnig, J. Peleg, et al. 1987. Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am. J. Vet. Res. 48:1138-1141.
21. Vanderzanden, L, M. Bray, D. Fuller, et al. 1998. DNA vaccines expressing either the GP or NP Genes of Ebola virus protect mice from lethal challenge. Virology 246:134-144.
22. Iacono-Connors, L.C., J. Novak, C. Rossi, et al. 1994. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies. Clin. Diagn. Lab. Immunol. 9(1):78-82.